FibroScan 可识别患有非酒精性脂肪性肝病和心血管损伤的患者。
FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage.
机构信息
Department of Pathophysiology and Transplantation Ca' Granda IRCCS Foundation, Policlinico Hospital, University of Milan, Milan, Italy.
Sezione di Gastroenterologia e Epatologia, Di.Bi.M.I.S., University of Palermo, Palermo, Italy.
出版信息
Clin Gastroenterol Hepatol. 2020 Feb;18(2):517-519. doi: 10.1016/j.cgh.2018.11.011. Epub 2018 Dec 8.
PMID:30528844
Abstract
Patients with nonalcoholic fatty liver disease (NAFLD), particularly in the presence of nonalcoholic steatohepatitis or fibrosis, are at high cardiac and cerebrovascular risk..
摘要
非酒精性脂肪性肝病（NAFLD）患者，尤其是存在非酒精性脂肪性肝炎或纤维化的患者，具有较高的心血管和脑血管风险。
Zotero 插件